Travere Therapeutics (NASDAQ:TVTX) Price Target Raised to $45.00 at Evercore ISI
Travere Therapeutics (NASDAQ:TVTX – Free Report) had its price target hoisted by Evercore ISI from $33.00 to $45.00 in a research note released on Wednesday,Benzinga reports. The brokerage currently ...
Scotiabank Forecasts Strong Price Appreciation for Travere Therapeutics (NASDAQ:TVTX) Stock
Travere Therapeutics (NASDAQ:TVTX – Free Report) had its price target boosted by Scotiabank from $27.00 to $32.00 in a research report released on Wednesday,Benzinga reports. Scotiabank currently has ...
Travere Therapeutics (TVTX): Among The Small–Cap Stocks Insiders Are Selling Recently
We recently published a list of 10 Small–Cap Stocks Insiders Are Selling Recently. In this article, we are going to take a look at where Travere Therapeutics, Inc. (NASDAQ:TVTX) stands against other ...
Wedbush Sticks to Their Hold Rating for Ultragenyx Pharmaceutical (RARE)
In a report released today, Laura Chico from Wedbush maintained a Hold rating on Ultragenyx Pharmaceutical (RARE – Research Report), with a ...
Travere Therapeutics price target raised to $47 from $45 at Guggenheim
Guggenheim analyst Vamil Divan raised the firm’s price target on Travere Therapeutics (TVTX) to $47 from $45 and keeps a Buy rating on the ...